Cargando…
Enzyme-mediated resistance to antibiotics : mechanisms, dissemination, and prospects for inhibition /
Antibiotic-resistant bacteria, or "superbugs," present an increasingly deadly threat to human health. With chapters from the world's leading researchers and scholars in this field, this comprehensive volume is a vital and timely overview of this critical subject.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
ASM Press,
©2007.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn646855073 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070117s2007 dcuaf ob 001 0 eng d | ||
| 010 | |z 2007002039 | ||
| 040 | |a E7B |b eng |e pn |c E7B |d OCLCQ |d CBT |d OCLCQ |d UIU |d OCLCF |d OCLCQ |d CUS |d EBLCP |d MERUC |d YDXCP |d UKDOC |d DEBSZ |d LLB |d ASMPP |d TMC |d OCLCQ |d AZK |d COCUF |d OCLCQ |d MOR |d Z5A |d YDX |d PIFAG |d ZCU |d OCLCQ |d N$T |d IGB |d OCLCO |d AGLDB |d OCLCO |d OCLCA |d U3W |d OCLCA |d CN8ML |d OCLCO |d D6H |d OCLCO |d OCLCQ |d STF |d WRM |d OCLCO |d VNS |d VTS |d NRAMU |d CRU |d ICG |d OCLCQ |d INT |d VT2 |d OCLCO |d OCLCQ |d OCLCO |d WYU |d OCLCO |d OCLCA |d S9I |d TKN |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d DKC |d OCLCQ |d M8D |d OCLCO |d OCLCA |d CEF |d HS0 |d VLY |d AJS |d OCLCO |d OCL |d OCLCQ | ||
| 015 | |a GBA740149 |2 bnb | ||
| 016 | 7 | |z 101297478 |2 DNLM | |
| 016 | 7 | |z 013752605 |2 Uk | |
| 019 | |a 536301412 |a 609853193 |a 764528550 |a 897090918 |a 961490898 |a 962682142 |a 1100831539 |a 1162576163 |a 1241797367 |a 1300652841 | ||
| 020 | |a 9781555815615 |q (electronic bk.) | ||
| 020 | |a 1555815618 |q (electronic bk.) | ||
| 020 | |z 9781555813031 | ||
| 020 | |z 1555813038 | ||
| 020 | |a 1283033917 | ||
| 020 | |a 9781283033916 | ||
| 020 | |a 9786613033918 | ||
| 020 | |a 661303391X | ||
| 024 | 7 | |a 10.1128/9781555815615 |2 doi | |
| 029 | 1 | |a AU@ |b 000053268418 | |
| 029 | 1 | |a DEBBG |b BV044141078 | |
| 029 | 1 | |a DEBSZ |b 430802137 | |
| 029 | 1 | |a DEBSZ |b 456458956 | |
| 029 | 1 | |a GBVCP |b 785180826 | |
| 029 | 1 | |a NZ1 |b 13861769 | |
| 035 | |a (OCoLC)646855073 |z (OCoLC)536301412 |z (OCoLC)609853193 |z (OCoLC)764528550 |z (OCoLC)897090918 |z (OCoLC)961490898 |z (OCoLC)962682142 |z (OCoLC)1100831539 |z (OCoLC)1162576163 |z (OCoLC)1241797367 |z (OCoLC)1300652841 | ||
| 037 | |b American Society for Microbiology Press |n www.ASMscience.org | ||
| 050 | 4 | |a QR177 |b .E59 2007eb | |
| 060 | 1 | 0 | |a QV 350 |b E615 2007 |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.9/041 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Enzyme-mediated resistance to antibiotics : |b mechanisms, dissemination, and prospects for inhibition / |c editors, Robert A. Bonomo, Marcelo Tolmasky. |
| 260 | |a Washington, D.C. : |b ASM Press, |c ©2007. | ||
| 300 | |a 1 online resource (xviii, 357 pages, 8 unnumbered pages of plates) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Overview of aminoglycosides and enzyme-mediated bacterial resistance: clinical implications / Robert A. Bonomo -- Aminoglycoside antibiotics / Kanchana Majumder [and others] -- Structural aspects of aminoglycoside-modifying enzymes / Gerard D. Wright and Albert M. Berghuis -- Aminoglycoside-modifying enzymes: characteristics, localization, and dissemination / Marcelo E. Tolmasky -- rRNA methylases and resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone (MLSKO) antibiotics / Marilyn C. Roberts -- [Beta]-lactamases: historical perspectives / Karen Bush and Patricia A. Bradford -- Resistance mediated by penicillin-binding proteins / Malcolm G.P. Page -- Inhibition of class A [beta]-lactamases / Samy O. Meroueh, Jooyoung Cha, And Shahriar Mobashery -- Class B [beta]-lactamases / Gian Maria Rossolini and Jean-Denis Docquier -- Crystal structures of class C [beta]-lactamases: mechanistic implications and perspectives in drug design / C. Bauvois and J. Wouters. | |
| 505 | 0 | |a Class D [beta]-lactamases / Franck Danel, Malcolm G.P. Page, and David M. Livermore -- Kinetics of [beta]-lactamases and penicillin-binding proteins / Moreno Galleni and Jean-Marie Frère -- The pharmaceutical industry and inhibitors of bacterial enzymes: implications for drug development / David M. Shlaes, Lefa Alksne, and Steven J. Projan -- [Beta]-lactamase inhibitory proteins / Zhen Zhang and Timothy Palzkill -- Active drug efflux in bacteria / Jürg Dreier -- Overview of dissemination mechanisms of genes coding for resistance to antibiotics / Marcelo E. Tolmasky -- Conjugative transposons / Louis B. Rice -- The dissemination of antibiotic resistance by bacterial conjugation / Virginia L. Waters -- Bacterial toxin-antitoxin systems as targets for the development of novel antibiotics / Juan C. Alonso [and others] -- Integrons and superintegrons / Robert A. Bonomo, Andrea M. Hujer, and Kristine M. Hujer -- The biological cost of antibiotic resistance / Dan I. Andersson [and others]. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Antibiotic-resistant bacteria, or "superbugs," present an increasingly deadly threat to human health. With chapters from the world's leading researchers and scholars in this field, this comprehensive volume is a vital and timely overview of this critical subject. | ||
| 546 | |a English. | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 650 | 0 | |a Drug resistance in microorganisms. | |
| 650 | 0 | |a Drug resistance in microorganisms |x Genetic aspects. | |
| 650 | 0 | |a Microbial enzymes. | |
| 650 | 0 | |a Enzyme inhibitors. | |
| 650 | 1 | 2 | |a Anti-Bacterial Agents |
| 650 | 1 | 2 | |a Drug Resistance, Bacterial |
| 650 | 2 | 2 | |a Enzyme Inhibitors |
| 650 | 2 | 2 | |a beta-Lactamase Inhibitors |
| 650 | 6 | |a Enzymes microbiennes. | |
| 650 | 6 | |a Bactéries pathogènes |x Résistance aux médicaments. | |
| 650 | 6 | |a Antienzymes. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Enzyme inhibitors. |2 fast |0 (OCoLC)fst00913597 | |
| 650 | 7 | |a Drug resistance in microorganisms. |2 fast |0 (OCoLC)fst00898704 | |
| 650 | 7 | |a Drug resistance in microorganisms |x Genetic aspects. |2 fast |0 (OCoLC)fst00898705 | |
| 650 | 7 | |a Microbial enzymes. |2 fast |0 (OCoLC)fst01019490 | |
| 700 | 1 | |a Bonomo, Robert A., |e editor. | |
| 700 | 1 | |a Tolmasky, Marcelo, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Enzyme-mediated resistance to antibiotics. |d Washington, D.C. : ASM Press, ©2007 |z 9781555813031 |w (DLC) 2007002039 |w (OCoLC)80019936 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1084303 |z Texto completo |
| 938 | |a 123Library |b 123L |n 2803 | ||
| 938 | |a ASM Press |b ASMP |n scna000076 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL476482 | ||
| 938 | |a ebrary |b EBRY |n ebr10346883 | ||
| 938 | |a EBSCOhost |b EBSC |n 1084303 | ||
| 938 | |a YBP Library Services |b YANK |n 3163334 | ||
| 994 | |a 92 |b IZTAP | ||